Masimo Retained Earnings (Accumulated Deficit) 2010-2024 | MASI
Masimo retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Masimo retained earnings (accumulated deficit) for the quarter ending December 31, 2024 were $1.491B, a 16.98% decline year-over-year.
- Masimo retained earnings (accumulated deficit) for 2024 were $1.491B, a 16.98% decline from 2023.
- Masimo retained earnings (accumulated deficit) for 2023 were $1.796B, a 4.75% increase from 2022.
- Masimo retained earnings (accumulated deficit) for 2022 were $1.714B, a 9.14% increase from 2021.
| Masimo Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $1,491 |
| 2023 | $1,796 |
| 2022 | $1,714 |
| 2021 | $1,571 |
| 2020 | $1,341 |
| 2019 | $1,100 |
| 2018 | $931 |
| 2017 | $738 |
| 2016 | $589 |
| 2015 | $289 |
| 2014 | $205 |
| 2013 | $133 |
| 2012 | $74 |
| 2011 | $69 |
| 2010 | $6 |
| 2009 | $94 |
| Masimo Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-12-31 | $1,491 |
| 2024-09-30 | $1,841 |
| 2024-06-30 | $1,831 |
| 2024-03-31 | $1,815 |
| 2023-12-31 | $1,796 |
| 2023-09-30 | $1,762 |
| 2023-06-30 | $1,751 |
| 2023-03-31 | $1,736 |
| 2022-12-31 | $1,714 |
| 2022-09-30 | $1,674 |
| 2022-06-30 | $1,636 |
| 2022-03-31 | $1,617 |
| 2021-12-31 | $1,571 |
| 2021-09-30 | $1,503 |
| 2021-06-30 | $1,445 |
| 2021-03-31 | $1,395 |
| 2020-12-31 | $1,341 |
| 2020-09-30 | $1,271 |
| 2020-06-30 | $1,221 |
| 2020-03-31 | $1,165 |
| 2019-12-31 | $1,100 |
| 2019-09-30 | $1,048 |
| 2019-06-30 | $998 |
| 2019-03-31 | $954 |
| 2018-12-31 | $931 |
| 2018-09-30 | $884 |
| 2018-06-30 | $827 |
| 2018-03-31 | $783 |
| 2017-12-31 | $738 |
| 2017-09-30 | $720 |
| 2017-06-30 | $681 |
| 2017-03-31 | $635 |
| 2016-12-31 | $589 |
| 2016-09-30 | $374 |
| 2016-06-30 | $346 |
| 2016-03-31 | $316 |
| 2015-12-31 | $289 |
| 2015-09-30 | $264 |
| 2015-06-30 | $245 |
| 2015-03-31 | $226 |
| 2014-12-31 | $205 |
| 2014-09-30 | $184 |
| 2014-06-30 | $169 |
| 2014-03-31 | $155 |
| 2013-12-31 | $133 |
| 2013-09-30 | $123 |
| 2013-06-30 | $108 |
| 2013-03-31 | $91 |
| 2012-12-31 | $74 |
| 2012-09-30 | $117 |
| 2012-06-30 | $103 |
| 2012-03-31 | $85 |
| 2011-12-31 | $69 |
| 2011-09-30 | $56 |
| 2011-06-30 | $41 |
| 2011-03-31 | $24 |
| 2010-12-31 | $6 |
| 2010-09-30 | $34 |
| 2010-06-30 | $18 |
| 2010-03-31 | $3 |
| 2009-12-31 | $94 |
| 2009-09-30 | $80 |
| 2009-06-30 | $67 |
| 2009-03-31 | $54 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.993B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $189.754B | 83.11 |
| Thermo Fisher Scientific (TMO) | United States | $159.887B | 19.34 |
| Alcon (ALC) | Switzerland | $48.486B | 32.23 |
| Edwards Lifesciences (EW) | United States | $44.472B | 29.10 |
| IDEXX Laboratories (IDXX) | United States | $37.951B | 43.61 |
| DexCom (DXCM) | United States | $32.004B | 49.47 |
| IQVIA Holdings (IQV) | United States | $27.061B | 14.97 |
| Mettler-Toledo (MTD) | United States | $22.925B | 27.19 |
| STERIS (STE) | Ireland | $22.088B | 25.26 |
| Waters (WAT) | United States | $20.850B | 29.52 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.568B | 0.00 |
| Hologic (HOLX) | United States | $12.153B | 13.11 |
| Sysmex ADR (SSMXY) | Japan | $11.545B | 0.00 |
| Penumbra (PEN) | United States | $11.463B | 89.97 |
| Globus Medical (GMED) | United States | $9.891B | 22.90 |
| Teleflex (TFX) | United States | $5.586B | 9.22 |
| Glaukos (GKOS) | United States | $5.006B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.385B | 22.97 |
| PROCEPT BioRobotics (PRCT) | United States | $3.077B | 0.00 |
| TransMedics (TMDX) | United States | $3.044B | 89.09 |
| Veracyte (VCYT) | United States | $2.377B | 42.75 |
| Nihon Kohden (NHNKY) | Japan | $2.113B | 11.55 |
| LivaNova (LIVN) | United Kingdom | $2.005B | 12.14 |
| Elekta AB (EKTAY) | Sweden | $1.960B | 17.62 |
| Alphatec Holdings (ATEC) | United States | $1.754B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.431B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.302B | 6.58 |
| Pulse Biosciences (PLSE) | United States | $1.156B | 0.00 |
| OPKO Health (OPK) | United States | $1.098B | 0.00 |
| Artivion (AORT) | United States | $0.996B | 93.32 |
| AxoGen (AXGN) | United States | $0.780B | 0.00 |
| IRadimed (IRMD) | United States | $0.680B | 35.65 |
| Mesa Laboratories (MLAB) | United States | $0.647B | 14.14 |
| RxSight (RXST) | United States | $0.644B | 0.00 |
| SiBone (SIBN) | United States | $0.595B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.565B | 9.10 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.538B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.520B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.513B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.457B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.415B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| NeuroPace (NPCE) | United States | $0.392B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.377B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.347B | 7.36 |
| Pacific Biosciences Of California (PACB) | United States | $0.339B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.333B | 17.82 |
| Neuronetics (STIM) | United States | $0.301B | 0.00 |
| CVRx (CVRX) | United States | $0.207B | 0.00 |
| 908 Devices (MASS) | United States | $0.200B | 0.00 |
| Inogen (INGN) | United States | $0.194B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.183B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.160B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.158B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.135B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.132B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.102B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.083B | 0.00 |
| InspireMD (NSPR) | Israel | $0.083B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 10.82 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.036B | 0.00 | |
| Biosig Technologies (BSGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.014B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.32 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |